An evaluation is requested for a 48-year-old male who is admitted to the intensive care un… — USMLE Step 2 CK

An evaluation is requested for a 48-year-old male who is admitted to the intensive care unit with a 4-day history of coughing up blood-tinged sputum, progressive dyspnea, and passing dark red urine. Over the past six months, he has been treated three times for therapy-resistant maxillary sinusitis and chronic otitis media. Vital signs show a temperature of $37.6^\circ\text{C}$ ( $99.7^\circ\text{F}$ ), blood pressure of $165/95\text{ mm Hg}$ , heart rate of $110/\text{min}$ , and respiratory rate of $26/\text{min}$ . Oxygen saturation is $89\%$ on room air. Physical examination reveals ulceration of the nasal septum and bilateral coarse crackles in the lung fields. Laboratory results are as follows:

Test	Result	Reference Range
Serum creatinine	$2.8\text{ mg/dL}$	$0.6-1.2\text{ mg/dL}$
TSH	$1.2\text{ }\mu\text{U/mL}$	$0.5-5.0\text{ }\mu\text{U/mL}$
Free T4	$0.6\text{ ng/dL}$	$0.9-1.7\text{ ng/dL}$
Arterial pH	$7.24$	$7.35-7.45$
$\text{pCO}_2$	$24\text{ mm Hg}$	$35-45\text{ mm Hg}$
$\text{HCO}_3^-$	$10\text{ mEq/L}$	$22-28\text{ mEq/L}$

Urinalysis demonstrates $3+$ blood, $1+$ protein, $30-40$ dysmorphic red blood cells per high-power field, and occasional red blood cell casts. Chest radiography reveals diffuse bilateral alveolar opacities.

Which of the following is the most appropriate next step in the management of this patient?

Begin therapy with systemic glucocorticoids and rituximabAnswer
B
Administer broad-spectrum intravenous antibiotics
C
Administer intravenous sodium bicarbonate
D
Provide nebulized bronchodilators and ipratropium
E
Initiate daily oral levothyroxine supplementation

Answer

Begin therapy with systemic glucocorticoids and rituximab

The correct next step is to begin therapy with systemic glucocorticoids and rituximab. This patient presents with the classic triad of Granulomatosis with polyangiitis (GPA): upper respiratory tract involvement (chronic sinusitis, otitis media, nasal septal ulceration), lower respiratory tract involvement (hemoptysis from diffuse alveolar hemorrhage), and renal involvement (rapidly progressive glomerulonephritis evidenced by acute kidney injury with dysmorphic RBCs and RBC casts). The simultaneous presence of acute alveolar hemorrhage and rapidly declining renal function is a life-threatening presentation known as pulmonary-renal syndrome. Immediate induction therapy with high-dose systemic glucocorticoids combined with an immunosuppressant (either rituximab or cyclophosphamide) is strictly required to halt progressive multi-organ destruction and preserve organ function.

Step-by-Step Solution

Identify the primary triad of symptoms in the clinical vignette.

The patient has upper respiratory tract disease (chronic sinusitis, nasal septal ulceration), lower respiratory tract disease (hemoptysis, bilateral alveolar opacities), and renal disease (acute kidney injury with dysmorphic RBCs and RBC casts).

Recognizing this classic triad establishes the clinical diagnosis of Granulomatosis with polyangiitis (GPA), an ANCA-associated vasculitis.

Evaluate the severity of the patient's presentation.

The patient has diffuse alveolar hemorrhage causing hypoxemia and rapidly progressive glomerulonephritis.

This constellation is known as pulmonary-renal syndrome, which is a life-threatening medical emergency requiring immediate, aggressive intervention.

Select the appropriate pharmacological management based on the diagnosis and severity.

Induction therapy with high-dose systemic glucocorticoids combined with either rituximab or cyclophosphamide is chosen.

Aggressive immunosuppression is the standard of care to halt autoimmune tissue destruction, prevent irreversible renal failure, and resolve alveolar hemorrhage in severe GPA.

Rule out competing distractors by analyzing the remaining laboratory data.

The acid-base status represents a pure, appropriately compensated metabolic acidosis via Winter's formula (

1.5 \times 10 + 8 = 23 \pm 2

). The thyroid panel indicates euthyroid sick syndrome (low T4, normal TSH in critical illness).

Proper data interpretation confirms that sodium bicarbonate and levothyroxine are unindicated and incorrect management steps.

Key Concept

Patients with Granulomatosis with polyangiitis (GPA) presenting with life-threatening pulmonary-renal syndrome require emergent induction immunosuppressive therapy with high-dose systemic glucocorticoids and rituximab or cyclophosphamide.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic